Teizeild
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Teizeild, covering 2025-11-14 to 2026-04-17. Get the full timeline:
Most recent: EMA Authorised: Teizeild (teplizumab) — Sanofi Winthrop Industrie
2 regulatory and trial events tracked for Teizeild, covering 2025-11-14 to 2026-04-17. Get the full timeline:
Most recent: EMA Authorised: Teizeild (teplizumab) — Sanofi Winthrop Industrie